Non-Steroidal Anti-Inflammatory Drugs Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Non-Steroidal Anti-Inflammatory Drugs Market, By Indication (Arthritis, Migraine, Ophthalmic Diseases, Others), By Route of Administration(Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of Non-Steroidal Anti-Inflammatory Drugs Market

The major players operating in the non-steroidal anti-inflammatory drugs market include Pfizer Inc., Johnson & Johnson Services, Inc., Bayer AG, Sanofi, GSK plc, Heron Therapeutics, Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group PLC, and Assertio Holdings, Inc.

Non-Steroidal Anti-Inflammatory Drugs Market Leaders

  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Sanofi
  • GSK plc
*Disclaimer: Major players are listed in no particular order.

Non-Steroidal Anti-Inflammatory Drugs Market - Competitive Rivalry, 2023

Market Concentration Graph

Non-Steroidal Anti-Inflammatory Drugs Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

Non-Steroidal Anti-Inflammatory Drugs Market Report Snapshots

Buy Now